Efficacy of intraperitoneal thermochemotherapy and immunotherapy in intraperitoneal recurrence after gastrointestinal cancer resection
نویسندگان
چکیده
منابع مشابه
Intraperitoneal recurrence of renal haemangiopericytoma
We describe a case of a 53 years old patient who underwent right nephrectomy for a renal tumor in 2005. The histological examination revealed an hemangiopericytoma with graveness signs. Ten years later, the patient developed a huge abdominal mass. CT scan showed a voluminous locally advanced tumor measuring 30*20 cm. The mass was multilobed and hypervascularized (A) Witch was compatible with a ...
متن کاملProlonged survival after intraperitoneal interleukin-2 immunotherapy for recurrent ovarian cancer
•A case report of a 14 year remission of recurrent ovarian cancer with intraperitoneal aldesleukin (IL-2) is presented.•Intraperitoneal IL-2 was given with little toxicity.•Immunotherapy may have the potential for durable remissions in ovarian cancer.
متن کاملIntraperitoneal Therapy of Ovarian Cancer.
PURPOSE: This is a review of the rationale for the intraperitoneal administration of antineoplastic agents in the management of ovarian cancer. PATIENTS AND METHODS: Patients have been treated in a number of clinical trials to define the toxicity profile and efficacy of intraperitoneal therapy in this clinical setting. RESULTS: Phase I-II trials have confirmed that a number of cytotoxic and bio...
متن کاملIntraperitoneal cytology after laparoscopic hysterectomy in patients with endometrial cancer
The aim of this study was to evaluate the dissemination of cancer cells at laparoscopic hysterectomy according to the intraperitoneal cytology.Patients with endometrial cancer underwent total laparoscopic modified radical hysterectomy. Peritoneal wash cytology was performed on entering the peritoneal cavity before surgical preparation and just after hysterectomy.Seventy-eight patients underwent...
متن کاملIntraperitoneal cisplatin and paclitaxel in ovarian cancer.
BACKGROUND Standard chemotherapy for newly diagnosed ovarian cancer is a platinum-taxane combination. The Gynecologic Oncology Group conducted a randomized, phase 3 trial that compared intravenous paclitaxel plus cisplatin with intravenous paclitaxel plus intraperitoneal cisplatin and paclitaxel in patients with stage III ovarian cancer. METHODS We randomly assigned patients with stage III ov...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: World Journal of Gastroenterology
سال: 2002
ISSN: 1007-9327
DOI: 10.3748/wjg.v8.i6.1019